Loading viewer...
report
Format: PDF report
This report presents preliminary efficacy, safety, and mutational status of ABI-009 in advanced malignant PEComa from an open-label Phase 2 trial.
37 Pages
report
Bio-Rad Laboratories
report
888 Holdings plc
report
Cerner Corporation
report
Parsons